Keith Carpenter
Net worth: 5 007 $ as of 2026-06-29
Net worth: 5 007 $ as of 2026-06-29
Mr. Keith Carpenter, CFA MBA, is a Chief Investment & Strategy Officer at ZYUS Life Sciences, Inc. Mr. Carpenter was previously employed as a Chief Strategy & Investment Officer by ZYUS Life Sciences Corp., an Independent Non-Executive Director by Fengro Industries Corp., a Research Analyst by Canaccord Adams, an Analyst by Canaccord Genuity Corp., a Managing Director-Equity Research & Agriculture by Canaccord Genuity Corp., a Portfolio Manager by Interward Asset Management Ltd., and an Associate by BMO Capital Markets Corp.
(Canada).
He also served on the board at ATB Capital Markets, Inc. He received his undergraduate degree from Yale University and an MBA from Rotman School of Management.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-11-25 | 125,178 ( 0.16% ) | 5 007 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical manufacturing company | Chief Investment Officer | 2018-07-31 |
| Companies | Position | End |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Chief Investment Officer | 2026-05-31 |
ATB Cormark Capital Markets Inc.
ATB Cormark Capital Markets Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2017-12-31 |
Canaccord Genuity Corp.
Canaccord Genuity Corp. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 2014-12-31 |
Canaccord Adams
Canaccord Adams Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2010-04-21 |
Interward Asset Management Ltd.
Interward Asset Management Ltd. Investment ManagersFinance IAML focus on opportunities in North American small and mid-cap companies. The firm uses a rigorous fundamental analysis in achieving a consistent long-term investment performance. In making investment decisions, IAML’s investment process combines top-down sector identification and a strong bottom-up analysis. Their key selling criteria include setting price targets, monitoring performance against expectations, any change in fundamentals, identifying better alternatives and profit taking. | Portfolio Manager-Equities | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
BMO Capital Markets Corp. (Canada)
BMO Capital Markets Corp. (Canada) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ATB Cormark Capital Markets Inc.
ATB Cormark Capital Markets Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Canaccord Adams
Canaccord Adams Investment Banks/BrokersFinance Provides brokerage services | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fengro Industries Corp.
Fengro Industries Corp. Chemicals: AgriculturalProcess Industries Focuses on the acquisition, exploration and development of phosphate opportunities | Process Industries |
Interward Asset Management Ltd.
Interward Asset Management Ltd. Investment ManagersFinance IAML focus on opportunities in North American small and mid-cap companies. The firm uses a rigorous fundamental analysis in achieving a consistent long-term investment performance. In making investment decisions, IAML’s investment process combines top-down sector identification and a strong bottom-up analysis. Their key selling criteria include setting price targets, monitoring performance against expectations, any change in fundamentals, identifying better alternatives and profit taking. | Finance |
Canaccord Genuity Corp.
Canaccord Genuity Corp. Investment Banks/BrokersFinance Provides brokerage services | Finance |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical manufacturing company | Health Technology |
ZYUS Life Sciences Corp.
ZYUS Life Sciences Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes cannabinoid-based pharmaceutical drug product candidates and therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions